Searched for
METROPOLIS HEALTHCARE STOCKS
Last date to buy these four stocks for dividends. Do you own any?Investors have a final chance today, May 18, to purchase shares of Alicon Castalloy, Atishay, Man InfraConstruction, and Metropolis Healthc...- Dividends, stock splits: L&T, Havells among 15 stocks turning ex-date this week. Check detailsInvestors should note upcoming corporate actions. Several companies including GM Breweries, Havells India, and Larsen & Toubro will turn ex...
- Earnings are strong, but margin pain is coming; Dharmesh Kant on 3 sectors worth owning nowIndian corporate profits are currently strong. However, rising input costs present a significant challenge ahead. Investors should remain p...
- Stock Radar: Metropolis Healthcare breaks out from 2-month consolidation; likely to retest 2,000 levelsMetropolis Healthcare Ltd. experienced a breakout from a 2-month consolidation in July 2025, signaling potential for further upward movemen...
- I-Sec upgrades Metropolis Healthcare to Buy, lowers target price to Rs 2,250ICICI Securities has upgraded Metropolis Healthcare to Buy, setting a target price of Rs 2,250. The company reported a net profit of Rs 31....
- Add Metropolis Healthcare, target price Rs 2,335: ICICI SecuritiesICICI Securities maintains an Add rating on Metropolis Healthcare with a raised target price of Rs 2,335. Metropolis is acquiring Core Diag...
- Add Metropolis Healthcare, target price Rs 2279: ICICI SecuritiesMetropolis Healthcare Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 10551.60 Crore) operating in Hos...
- Buy Metropolis Healthcare, target price Rs 2135: Axis SecuritiesMetropolis Healthcare Ltd. key Products/Revenue Segments include Service Income for the year ending 31-Mar-2023.
- Buy Metropolis Healthcare, target price Rs 1969: BNP Paribas SecuritiesMetropolis Healthcare Ltd. key Products/Revenue Segments include Service Income for the year ending 31-Mar-2023.
- Buy Metropolis Healthcare, target price Rs 1420: Sharekhan by BNP ParibasMetropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6849.87 Crore) operating in Hospitals...
- Buy Metropolis Healthcare, target price Rs 1775: JM FinancialMetropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6731.32 Crore) operating in Hospitals...
- Buy Metropolis Healthcare, target price Rs 1978: BNP Paribas SecuritiesPromoters held 49.79 per cent stake in the company as of 30-Jun-2022, while FIIs owned 23.2 per cent, DIIs 14.5 per cent.
- Buy Metropolis Healthcare, target price Rs 1926: ICICI SecuritiesMetropolis Healthcare Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 8295.68 Crore) operating in Hosp...
- Buy Metropolis Healthcare, target price Rs 1700: JM FinancialMetropolis Healthcare Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 7237.90 Crore) operating in Hosp...
- Buy Metropolis Healthcare, target price Rs 1735: Yes SecuritiesMetropolis Healthcare Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 7804.15 Crore) operating in Hosp...
- Buy Metropolis Healthcare, target price Rs 2187: ICICI SecuritiesMetropolis Healthcare Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 7449.51 Crore) operating in Hosp...
- Buy Metropolis Healthcare, target price Rs 2187: ICICI SecuritiesMetropolis Healthcare Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 7811.42 Crore) operating in Hosp...
- Metropolis Healthcare's reasonable valuation and other factors that make it this week's stock pickBrand visibility, advanced technology and specialised testing are expected to help Metropolis increase its customer base. Its recent acquis...
- Metropolis Healthcare up 0.7% as board approves acquisition of Hitech DiagnosticMetropolis Healthcare said the deal would be worth Rs 636 crore.
- Metropolis Healthcare jumps 9% as Q4 profit multipliesIn Q4, the company recorded its highest ever quarterly revenue largely led by a healthy recovery in non-Covid and increased Covid testing o...
Load More
